CLINICAL TRIAL SUMMARY

MDACC Study No:2011-1036 (clinicaltrials.gov NCT No: NCT01512589)
Title:Phase III Randomized Trial of Proton Beam Therapy versus Intensity-Modulated Radiation Therapy for the treatment of esophageal cancer
Principal Investigator:Steven H. Lin
Treatment Agent:5-Fluorouracil; Docetaxel; Intensity Modulated Radiotherapy; Proton Therapy
Study Status:Open
Study Description:The goal of this clinical research study is to learn how safe and effective
proton-beam therapy (PBT) may be in comparison to intensity modulated radiation
therapy (IMRT) in combination with chemotherapy in patients with esophageal
cancer.

PBT and IMRT are both forms of radiation therapy that are designed to treat a
specific area of the body while affecting as little of the surrounding normal
tissue as possible. PBT is a newer technology that is designed to further
reduce the amount of radiation that affects the surrounding normal tissue.
However, this is still being studied.

Hide details for General InformationGeneral Information

Disease Group:Esophagus
Phase of Study:Phase III
Treatment Agents:5-Fluorouracil
Docetaxel
Intensity Modulated Radiotherapy
Proton Therapy
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:
Supported By:N/A
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Steven H. Lin
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults